@DanielKalbacher

Interventional Cardiology. Structural Heart Disease. Echocardiography.

 Hamburg, Deutschland
Joined October 2019
  • Tweets156
  • Following1K
  • Followers576
14Media
Daniel Kalbacher retweeted
CJC Journals
@CJCJournals17 May 2023
Check out this new #CJC #Editorial which: highlights the challenges of the TMVR screening process & provides a Glimpse into the Future Technological Needs and Requirements 👉 onlinecjc.ca/article/S0828-2…
5
7
1,347
Daniel Kalbacher retweeted
Moritz Nies@MoritzNies13 Apr 2023
A cautionary tale about the transient dysfunction of a leadless pacemaker system after cardioversion - Be ready to pace! Just published online in Heart Rhythm Case Reports @JNikorowitsch heartrhythmcasereports.com/a…

Transient dysfunction of leadless pacemaker system after cardioversion

Leadless cardiac pacemakers were introduced as a novel approach to treat bradyarrhythmias, overcoming the risk of lead- and pocket-associated complications of transvenous pacemakers.1–3 Recently, a...

heartrhythmcasereports.com
3
3
12
1,664
#LateBreakingClinicalTrials: In seinem Vortrag bei der #DGKJahrestagung präsentiert Prof. B. Köll das PRIME-MR Register.
4
15
1,792
Daniel Kalbacher retweeted
Andrea Scotti@AndreaScotti219 Mar 2023
🗞️ The EXPAND study is now out on #EJHF @ESC_Journals In our Editorial: 🎯#MitraClip NTR vs. XTR 🎯1y results w/ MitraClip 3rd gen 🎯how to reduce leaflet injury & SLDA 🌐Editorial: onlinelibrary.wiley.com/doi/… 🌐Article: onlinelibrary.wiley.com/doi/… @azeemlatib #CardioED #MedEd #TEER
2
11
2
31
6,180
Daniel Kalbacher retweeted
Jonathan Curio@CurioJonathan1 Dec 2022
#PRIMEMR @BenediktKoell @SebLudwig1 @AndreaScotti21 @AugustinCoisne @DanielKalbacher
TCTMD
@TCTMD1 Dec 2022
Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain dlvr.it/SdhJpc
2
6
Transcatheter tricuspid valve replacement is emerging as a therapeutic option amongst patients with secondary tricuspid regurgitation. This systematic review and meta-analysis provides an overview of the early and late outcomes after isolated surgical TVR. ow.ly/c1jN50L1I5O
1
18
2
51
Cath lab personal before starting elective PCI receiving results of the REVIVED-BCIS2 trial
1
7
Daniel Kalbacher retweeted
Kashish Goel
@kashishgoelmd21 Aug 2022
Want to know the outcomes of MitraClip in secondary MR since FDA approval? Come join me at #ESC2022 where I will be presenting the COAPT Post Approval Study as a Late-Breaker on Aug 28 @PaulMahoneyMD @PradeepYadavMD @_WayneBatchelor @JasonHRogersMD @colinbarkerMD @ESC_Journals
17
18
3
189
Daniel Kalbacher retweeted
Philippe Pibarot@PPibarot11 Aug 2022
Atrial FMR is a frequent cause of FMR and can be effectively treated with TEER to improve symptoms at follow-up. Transcatheter Mitral Valve Repair in Patients With Atrial Functional Mitral Regurgitation pubmed.ncbi.nlm.nih.gov/3584…
5
24
71
Daniel Kalbacher retweeted
JACC Journals@JACCJournals1 Aug 2022
M-TEER for atrial functional #mitralvalve regurgitation (FMR)? Atrial FMR is a frequent cause of FMR & can be effectively treated w/ #MTEER. Check out the new results from EuroSMR registry: bit.ly/3oI9Us3 #JACCIMG #cvImaging #MitraClip #CardioTwitter #echofirst #vhdMR
23
3
55
Daniel Kalbacher retweeted
Nils Soerensen@Nils_Soensen1 Jul 2022
Lucky Friday 🍀
31
347
43
2,534
Daniel Kalbacher retweeted
JACC Journals@JACCJournals27 Jun 2022
ICYMI: A new staging classification of primary #vhdMR based on extra-mitral valve cardiac involvement, including severe LA dilatation & RV dysfunction, showed independent prognostic value. bit.ly/3x8gzPW #JACCIMG #EchoFirst #cvImaging
15
55
Daniel Kalbacher retweeted
Dr.PZ
@DrPZPZ26 Jun 2022
👍🏻👍🏻@NEJM #mybodymychoice – at Uetze, Deutschland
3
3
Daniel Kalbacher retweeted
Elliot Tapper@ebtapper20 Jun 2022
A patient with diabetes and recent NSTEMI treated with stent, clopidogrel, and atorvastatin ~2 months ago is transferred from OSH with ALT 1500, bilirubin 15 The leading diagnosis is statin liver injury But that's not what it is. Not at all 🧵 #livertwitter #liverstory
32
310
73
1,239
Failed vascular closure device after large-bore femoral access
2
23
Daniel Kalbacher retweeted
RTHahnMD
@hahn_rt14 May 2022
Mean gradient outcomes post Mitral-TEER remain uncertain. See recent studies/Editorial: bit.ly/Koell_TEERMPG bit.ly/Yoon_TEERMPG bit.ly/MnGrad_Editorial @JACCJournals @ACCinTouch @escardio @BenediktKoell @DanielKalbacher @jeroenjbax1 @JHausleiter
43
91
Daniel Kalbacher retweeted
Benedikt Koell@BenediktKoell6 May 2022
Proud to share our latest analysis on the impact of elevated transmitral pressure gradient following M-TEER. Just published in JACC: Int #JACCJournals ➡️ authors.elsevier.com/a/1f01q… Elevated gradient predicts outcomes in DMR, but not in FMR! @SebLudwig1 @DanielKalbacher
1
10
1
27
AHEAD OF PRINT: The results of this study emphasise the strengths and limitations of transcatheter mitral valve implantation (#TMVI) as a novel and promising therapy providing predictable elimination of mitral regurgitation in most patients. #EAPCI ow.ly/t3iI50HpME5
16
27
Daniel Kalbacher retweeted
Peter Lüdike@luedike7 Dec 2021
Impact of Mitral Valve Repair Technologies on Predictability of Post-Delivery Residual Mitral Regurgitation @DGK_org @escardio @AGIKinterv @JACCJournals @AHAMeetings
10
1
33
Daniel Kalbacher retweeted
Benedikt Koell@BenediktKoell7 Dec 2021
Excited to see our work online! @JACCJournals In contrast to MITRA-FR, COAPT enrollment criteria identify a phenotype of patients with SMR and lower mortality rates following M-TEER. jacc.org/doi/10.1016/j.jacc.… @DanielKalbacher
4
17
1
69
Load more